Federal multidistrict litigation against Bayer AG and Johnson & Johnson over the blood thinner Xarelto is beginning to take shape in Louisiana, where plaintiffs lawyers are gunning for a reprise of a $650 million settlement with Boehringer Ingelheim over a similar drug.
But for now the plaintiffs are still jousting over who will take the lead.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
